Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
This section weighs security guarantees across Pow and Pos, helping readers decide which consensus offers stronger protections for their needs.
24,327 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Embecta faced a sharp decline after its quarterly report, leaving investors wondering about the near-term outlook. Th...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
XRP faces a pivotal moment as regulatory clarity grows and ETF options inch closer. Analysts lay out the conditions t...
The stock market is flirting with a milestone not seen in 155 years. This article explains what a stock market verge ...
Analysts weigh a path to $400 per share by 2028 as Apple rides iPhone demand and Services expansion, even as market h...
Micron stock surged last month on AI memory demand and strong results, then faced a July pullback as traders reassess...
AI hardware competition now hinges on storage alongside compute. NVIDIA drives data-center growth, while SanDisk ride...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
MercadoLibre stock slid 17% in the past month as JPMorgan cut its target to $2,100, citing fierce competition and mar...
Tesla reports its first European sales uptick in over a year, a modest but meaningful turn that investors are watchin...
Rising college costs and changing job markets are pushing families to rethink Ivy League prestige. A new wave of non-...